Update on the Impact of Comorbidities on the Efficacy and Safety of Heart Failure Medications

被引：0
|
作者：
Christine Chow
Robert J. Mentz
Stephen J. Greene
机构：
[1] Duke University School of Medicine,Division of Cardiology
[2] Duke University School of Medicine,undefined
[3] Duke Clinical Research Institute,undefined
来源：
Current Heart Failure Reports | 2021年 / 18卷
关键词：
Heart failure; Comorbidities; SGLT2 inhibitors; Sacubitril-valsartan; Mineralocorticoid receptor antagonists; Beta-blockers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：132 / 143
页数：11
相关论文
共 50 条
  • [31] Impact of the number of comorbidities on cardiac sympathetic derangement in patients with reduced ejection fraction heart failure
    Bencivenga, Leonardo
    Komici, Klara
    Femminella, Grazia Daniela
    Paolillo, Stefania
    Gargiulo, Paola
    Formisano, Roberto
    Assante, Roberta
    Nappi, Carmela
    Puzone, Brunella
    Sepe, Immacolata
    Cittadini, Antonio
    Vitale, Dino Franco
    Ferrara, Nicola
    Cuocolo, Alberto
    Filardi, Pasquale Perrone
    Rengo, Giuseppe
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 86 : 86 - 90
  • [32] Impact of Sleep Apnea, Daytime Sleepiness, Comorbidities, and Depression on Patients' Heart Failure Health Status
    Piamjariyakul, Ubolrat
    Shapiro, April L.
    Wang, Kesheng
    Zulfikar, Rafia
    Petitte, Trisha
    Shafique, Saima
    Smith, Carol E.
    CLINICAL NURSING RESEARCH, 2021, 30 (08) : 1222 - 1230
  • [33] The Impact of Extra Cardiac Comorbidities on Pressure Volume Relations in Heart Failure and Preserved Ejection Fraction
    Abramov, Dmitry
    He, Kun-Lun
    Wang, Jie
    Burkhoff, Daniel
    Maurer, Mathew S.
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (07) : 547 - 555
  • [34] Safety and efficacy of new anticoagulants in patients with heart failure
    Pisters R.
    Lip G.Y.H.
    Current Heart Failure Reports, 2013, 10 (1) : 18 - 25
  • [35] Influence of Age on Efficacy and Safety of Spironolactone in Heart Failure
    Vardeny, Orly
    Claggett, Brian
    Vaduganathan, Muthiah
    Beldhuis, Iris
    Rouleau, Jean
    O'Meara, Eileen
    Anand, Inder S.
    Shah, Sanjiv J.
    Sweitzer, Nancy K.
    Fang, James C.
    Desai, Akshay S.
    Lewis, Eldrin F.
    Pitt, Bertram
    Pfeffer, Marc A.
    Solomon, Scott D.
    JACC-HEART FAILURE, 2019, 7 (12) : 1022 - 1028
  • [36] New medications for heart failure
    Gordin, Jonathan S.
    Fonarow, Gregg C.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2016, 26 (06) : 485 - 492
  • [37] β-blocker therapy of heart failure:: an update
    Metra, Marco
    Nodari, Savina
    Bordonali, Tania
    Milani, Patrizia
    Fracassi, Francesco
    Cas, Livio Dei
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (03) : 289 - 298
  • [38] Safety and Efficacy of Sertraline for Depression in Patients With Heart Failure
    O'Connor, Christopher M.
    Jiang, Wei
    Kuchibhatla, Maragatha
    Silva, Susan G.
    Cuffe, Michael S.
    Callwood, Dwayne D.
    Zakhary, Bosh
    Stough, Wendy Gattis
    Arias, Rebekka M.
    Rivelli, Sarah K.
    Krishnan, Ranga
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (09) : 692 - 699
  • [39] Update in the approach to and management of heart failure
    Gelow, Jill M.
    Fang, James C.
    SOUTHERN MEDICAL JOURNAL, 2006, 99 (12) : 1346 - 1355
  • [40] Trends in prevalence of comorbidities in heart failure clinical trials
    Khan, Muhammad Shahzeb
    Tahhan, Ayman Samman
    Vaduganathan, Muthiah
    Greene, Stephen J.
    Alrohaibani, Alaaeddin
    Anker, Stefan D.
    Vardeny, Orly
    Fonarow, Gregg C.
    Butler, Javed
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (06) : 1032 - 1042
12345